CIP
VERA icon

Chartwell Investment Partners’s Vera Therapeutics VERA Stock Holding History

Chartwell Investment Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$847K Buy
19,172
+7,447
+64% +$283K 0.03% 367
2024
Q2 		$424K Buy
+11,725
New +$465K 0.01% 402

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chartwell Investment Partners's VERA Position: Q3 2024 in Review

Chartwell Investment Partners increased its Vera Therapeutics (VERA) stake by 64% in Q3 2024, buying an estimated $283K and bringing the position to 19,172 shares worth $847K. The position accounts for 0.03% of the portfolio, ranked #367.

Chartwell Investment Partners first reported a position in VERA in Q2 2024 and has held it in 2 quarters since. 173 funds tracked by Wall St. Rank hold VERA as of Q3 2024.

  • Chartwell Investment Partners held 19,172 shares of Vera Therapeutics worth $847K as of Q3 2024.
  • Chartwell Investment Partners bought 7,447 Vera Therapeutics shares in Q3 2024, an estimated $283K.
  • Vera Therapeutics made up 0.03% of Chartwell Investment Partners's portfolio in Q3 2024, its #367 holding.
  • Chartwell Investment Partners first reported a position in Vera Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 173 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.